© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition
ORIGINAL ARTICLE
Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease
1 Neonatal Intensive Care Unit, Hope Hospital, Salford, UK
2 Department of Paediatrics, Royal Bolton Hospital, Bolton, UK
3 Immunobiology Unit, Institute of Child Health, Guilford Street, London, UK
4 Neonatal Intensive Care Unit, Hope Hospital, Salford, UK
Correspondence to:
Correspondence to:
Dr P Clarke, Neonatal Intensive Care Unit, Hope Hospital, Salford, UK;
paul.clarke{at}srht.nhs.uk
Aim: To assess whether a fourth Hib polysaccharide-tetanus protein conjugate vaccine (PRP-T) would improve antibody response in preterm infants previously treated with dexamethasone for chronic lung disease.
Methods: In a pilot study 12 infants born at less than 30 weeks gestation who had received corticosteroids were given a supplementary Hib dose six weeks after completion of the primary immunisation course. Serum samples obtained before and at eight weeks following the fourth Hib dose were analysed for total level and avidity of anti-PRP antibody.
Results: There was no significant increase in the geometric mean titre (GMT) of anti-PRP antibody resulting from the fourth Hib immunisation (GMT: pre 2.35 µg/ml, post 2.24 µg/ml, p = 0.79). A subgroup of six infants had subprotective antibody levels (<1.0 µg/ml) after the primary immunisation course, which remained subprotective following the extra Hib immunisation. Despite the poor response in total antibody level, the study group showed a significant rise in PRP specific IgG avidity following the fourth immunisation (GMAI: pre 0.076, post 0.138, p = 0.043).
Conclusion: An additional Hib immunisation given to recently steroid treated preterm infants six weeks after completion of the primary schedule did not augment primary immunogenicity. However, increasing avidity may imply successful priming and long term immunity to Hib.
Keywords: Haemophilus influenzae type b vaccine; immunisation; chronic lung disease; dexamethasone; avidity
Abbreviations: AI, avidity index; CLD, chronic lung disease; GMT, geometric mean titre; Hib, Haemophilus influenzae type b; PRP, polyribosylribitol phosphate; PRP-OMP, polyribosylribitol phosphate-outer membrane protein of meningococcus B; PRP-T, Hib polysaccharide-tetanus protein conjugate vaccine
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Robinson, M. J, Heal, C., Gardener, E., Powell, P., Sims, D. G.
(2004). Antibody Response to Diphtheria-Tetanus-Pertussis Immunization in Preterm Infants Who Receive Dexamethasone for Chronic Lung Disease. Pediatrics
113: 733-737
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



